Developing and integrating an orthobiologics curriculum
- PMID: 39011829
- DOI: 10.1002/pmrj.13252
Developing and integrating an orthobiologics curriculum
References
REFERENCES
-
- Everts P, Onishi K, Jayaram P, Lana JF, Mautner K. Platelet‐rich plasma: new performance understandings and therapeutic considerations in 2020. Int J Mol Sci. 2020;21(20):7794.
-
- Auriemma M, Borgstrom H, Itskevich D, et al. Curriculum for training in orthobiologics. PM&R. 2024;16(7):769‐771. doi:10.1002/pmrj.13249
-
- FDA News Release. FDA warns StemGenex biologic laboratories LLC of illegally marketing an unapproved cellular product manufactured in a facility with significant manufacturing violations, putting patients at risk. United States Food and Drug Administration. Accessed April 26, 2023. https://www.fda.gov/news‐events/press‐announcements/fda‐warns‐stemgenexb...
-
- Finnoff JT, Awan TM, Borg‐Stein J, et al. American Medical Society for Sports Medicine Position Statement: principles for the responsible use of regenerative medicine in sports medicine. Clin J Sport Med. 2021;31(6):530‐541.
-
- Shapiro SA, Finnoff JT, Awan TM, et al. Highlights from the American Medical Society for Sports Medicine position statement on responsible use of regenerative medicine and orthobiologics in sports medicine. Br J Sports Med. 2022;56(3):121‐122.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
